SCHEMBL7355364

SCHEMBL7355364

O=C1C(=CC=Cc2ccccc2)Oc2cc(O)ccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 1/20 0.65
▸ MEN1 O00255 8/20 0.63
▸ KMT2A Q03164 8/20 0.63
▸ USP2 O75604 3/20 0.63
▸ KDM4E B2RXH2 3/20 0.63
▸ MAPT P10636 3/20 0.63
▸ MAPK1 P28482 2/20 0.63
▸ PLIN1 O60240 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ PLIN5 Q00G26 1/20 0.63
▸ ABHD5 Q8WTS1 1/20 0.63
▸ MAOB P27338 4/20 0.58
▸ TYR P14679 4/20 0.58
▸ MAOA P21397 3/20 0.58
▸ CISD1 Q9NZ45 2/20 0.56
▸ CASP3 P42574 1/20 0.56
▸ SENP8 Q96LD8 1/20 0.56
▸ SENP7 Q9BQF6 1/20 0.56
▸ SENP6 Q9GZR1 1/20 0.56
▸ RECQL P46063 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5707772 0.83 MAOB (0.83) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL5707779 0.83 MAOB (0.83) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL21082590 0.83 STK17B (0.66) PIK3C3MEN1KMT2AUSP2KDM4E
SCHEMBL6963496 0.76 MEN1 (0.80) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL6963493 0.76 MEN1 (0.80) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL25426134 0.76 MAOB (0.79) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL6807842 0.76 USP2 (0.67) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL6807845 0.76 USP2 (0.67) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL6965152 0.74 MAOB (0.78) MEN1KMT2AUSP2KDM4EMAPT
SCHEMBL6965147 0.74 MAOB (0.78) MEN1KMT2AUSP2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6307051-B1 UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTAGONISTS AND HAVE ANTITUMOR AND ANTIMETASTATIC ACTIVITY. ROCHE DIAGNOSTICS GMBH (DE) 2001-10-23 — — US disclosed
EP-1026165-A1 O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents Roche Diagnostics GmbH (DE) 2000-08-09 — — EP disclosed
US-4486442-A ANTIANAPHYLACTIC BOEHRINGER MANNHEIM GMBH (DE) 1984-12-04 — — US disclosed
Send feedback